JPT offers a large portfolio of peptide products and services supporting all development phases of new cell therapies and vaccines. These products range from discovery tools for epitope and target identification, to various peptide formats for immune monitoring and clinical grade peptides to support clinical vaccination and cell therapy trials.

BioTides are biotinylated peptides synthesized by JPT's proprietary SPOT synthesis technology providing fast access to large numbers of biotin peptides at unmatched pricing. They are perfectly designed for biomedical screening assays that require immobilization onto streptavidin coated beads, membranes, glass slides or microtiter plates (e.g ...

JPT has a long standing and focused expertise to assist biomedical screening and peptide lead optimization programs with its comprehensive bioinformatic and cheminformatic capabilities. Statistical evaluation as well as visualization and presentation of complex data are performed using state of the art tools.

JPT Peptide Technologies GmbH公司是一家生产多肽和和基于多肽服务和相关产品的生物公司。产品主要应用于免疫学、基因组学和药物研究。JPT 的总部和生产基地位于德国柏林，公司开发了一系列专利产品，为蛋白组学、新型疫苗和药物开发提供支持。

JPT Peptide Technologies GmbH is a leading provider of innovative peptide-based services, and catalog products & kits, as well as a research and development partner for projects in Immunology, Proteomics and Drug Discovery. JPT's head office and production sites are located in Berlin, Germany.

2022年10月28日 · 成立于2004年的JPT Peptide Technologies GmbH（以下简称JPT），是一家为生物标志物发现、免疫监测和疫苗开发提供创新多肽研究工具和服务的综合供应商。 因在多肽领域的多年深厚积累，JPT被欧洲生物制药巨头BioNTech收购，并以全资子公司的身份继续提供一系列高质量的定制肽、临床肽、以及基于肽的创新产品，其多肽试剂被广泛应用于免疫学、蛋白组学以及药物发现等方面的应用。 多肽药物已日益成为全球新药研发的热点之一，但多肽药物的研 …

2024年4月29日 · JPT Peptide Technologies GmbH 是一家位于德国的生物技术公司，专注于为生命科学研究和诊断开发创新的肽基产品和技术服务。 在过去的 20 年里，我们在多肽制造方面积累了独t而广泛的专业知识，并在多肽库、池和微阵列以及微尺度合成领域开创了专li技术。

JPT是多肽相关的服务，目录产品或试剂盒 ，以及研究与发展伙伴和多肽相关的创新服务项目（免疫，蛋白组，药物发现 等）的提供者。 还没找到想要购买的产品吗？ 去顶部搜一搜. JPT多肽技术有限公司成立于2004年，源于总部设在柏林的肽的药物研发的 Jerini AG公司，2008年JPT成为bioNTech AG公司的全资子公司（美因茨，德国 ），已取得DIN ISO 9001:2008认证。 JPT是多肽相关的服务，目录产品或试剂盒 ，以及研究与发展伙伴和多肽相关的创新服务项目（免疫， …

JPT has developed several unique approaches which address all phases of the cell therapy & vaccine development process including biomarker discovery, neo-epitope prioritization, immune monitoring, and vaccine efficacy testing. In addition, the four technology platforms create the basis for targeted proteomics, as well as molecular diagnostics.

JPT Peptide Technologies GmbH是BioNTech AG的全资子公司，是免疫疗法、蛋白质组学和药物发现领域肽相关项目的研发合作伙伴和创新服务提供商，已通过DIN ISO 9001:2015认证。